UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044509
Receipt number R000050851
Scientific Title Research on bile duct biopsy for biliary tract diseases
Date of disclosure of the study information 2021/07/01
Last modified on 2021/06/22 20:47:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on bile duct biopsy for biliary tract diseases

Acronym

Research on bile duct biopsy for biliary tract diseases

Scientific Title

Research on bile duct biopsy for biliary tract diseases

Scientific Title:Acronym

Research on bile duct biopsy for biliary tract diseases

Region

Japan


Condition

Condition

Extrahepatic bile duct cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the results and safety of biopsy for bile duct stenosis using an endoscopic introducer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Success rate of Mapping Biopsy using endoscopic introducer (success rate of biopsy of targeted bile duct branch against expected operation)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Bile duct biopsy using an endoscopic introducer

Interventions/Control_2

Bile duct biopsy without an endoscopic introducer

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are suspected of having bile duct stenosis by imaging diagnosis such as CT or MRI and require ERCP.
Patients who have given written consent to participate in this study.

Key exclusion criteria

Patients with poorly controlled infections.
Patients with severe drug allergy.
Pregnant or potentially pregnant and lactating women.
Patients with severe mental disorders.
Cases that the principal investigator or sub-investigator deems inappropriate for the safe conduct of this study.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Kawashima

Organization

Nagoya University Hospital

Division name

Department of Endoscopy

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

TEL

0527442602

Email

h-kawa@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Kenta
Middle name
Last name Yamada

Organization

Nagoya University Hospital

Division name

Department of Endoscopy

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

TEL

0527442602

Homepage URL


Email

kentaymd@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

Nagoya University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee

Address

65, Tsuruma-cho, Showa-ku, Nagoya

Tel

0527412111

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 06 Month 11 Day

Date of IRB


Anticipated trial start date

2021 Year 07 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 06 Month 11 Day

Last modified on

2021 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050851


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name